SCHEMBL9932415

SCHEMBL9932415

CN(C(=O)O)C1CN(c2cc(-c3nc4ccccc4n3C)c(Cl)cn2)C1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 7/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
CYP2C9 P11712 2/20 0.40
SMO Q99835 7/20 0.40
OPRM1 P35372 1/20 0.38
OPRD1 P41143 1/20 0.38
OPRK1 P41145 1/20 0.38
OGFRL1 Q5TC84 1/20 0.38
HPGD P15428 1/20 0.37
USP2 O75604 1/20 0.37
LMNA P02545 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
MAPT P10636 1/20 0.37
TSHR P16473 1/20 0.37
MAPK1 P28482 1/20 0.37
CYP2C19 P33261 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9931941 0.93 OPRM1 (0.44) MEN1KMT2ACYP2C9SMOOPRM1
SCHEMBL9931893 0.93 MEN1 (0.41) PDE10AMEN1KMT2ACYP2C9SMO
SCHEMBL9933208 0.90 CYP2C9 (0.41) PDE10AMEN1KMT2ACYP2C9SMO
SCHEMBL9968394 0.90 PDE10A (0.41) PDE10AMEN1KMT2ACYP2C9SMO
SCHEMBL9932360 0.85 MAP4K4 (0.44) MEN1KMT2ACYP2C9SMO
SCHEMBL9931793 0.85 PDE10A (0.39) PDE10AMEN1KMT2ACYP2C9SMO
SCHEMBL9932029 0.84 MEN1 (0.44) PDE10AMEN1KMT2ACYP2C9SMO
SCHEMBL9932899 0.84 MEN1 (0.44) PDE10AMEN1KMT2ACYP2C9SMO
SCHEMBL9931884 0.84 MEN1 (0.44) PDE10AMEN1KMT2ACYP2C9SMO
SCHEMBL9932946 0.84 CYP2C9 (0.41) PDE10AMEN1KMT2ACYP2C9SMO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120157471-A1 BENZIMIDAZOLE DERIVATIVES PFIZER INC. (US) 2012-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120157471-A1 BENZIMIDAZOLE DERIVATIVES SMO, RB1, GLI1 PDE10A 1879/4885MEN1 1168/4885KMT2A 310/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.